|
|
||||||||
J Thorac Cardiovasc Surg 2003;126:1634-1635
© 2003 The American Association for Thoracic Surgery
Brief communications |
a Columbia University, College of Physicians and Surgeons, Division of Cardiothoracic Surgery, New York, NY, USA
Received for publication February 14, 2003; accepted for publication April 1, 2003.
* Address for reprints: Dr Y. Naka, New York Presbyterian Hospital, Columbia-Presbyterian Center, Division of Cardiothoracic Surgery, Millstein Hospital Bld 7-435, 177 Fort Washington Ave, New York, NY 10032, USA
yn22@columbia.edu
| The first 20% of the full text of this article appears below. |
We have established a regional referral network that facilitates the transfer of patients in cardiogenic shock to our center for definitive management. This "hub-and-spoke" network has proven to be effective in treating this critically ill population. Postcardiotomy shock complicates 2% to 6% of cardiac procedures.1 The incidence of cardiogenic shock following acute myocardial infarction (AMI) is 5% to 15%.2 Medical management composed of inotropes and pressors with or without intra-aortic balloon pump support represents the standard of care in treating these patients. The advent of left ventricular assist devices (LVADs) introduced a surgical option for cases refractory to medical management. This study delineates who survives in this population and how the postcardiotomy setting impacts device placement.
Methods
This was a retrospective review looking at the short-term outcome of the 46 patients transferred from 22 spoke institutions to 1 tertiary hub center between October 1993 and May
This article has been cited by other articles:
![]() |
R. John, J. W. Long, H. T. Massey, B. P. Griffith, B. C. Sun, A. J. Tector, O. H. Frazier, and L. D. Joyce Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support J. Thorac. Cardiovasc. Surg., April 1, 2011; 141(4): 932 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Hernandez, A. M. Shea, C. A. Milano, J. G. Rogers, B. G. Hammill, C. M. O'Connor, K. A. Schulman, E. D. Peterson, and L. H. Curtis Long-term Outcomes and Costs of Ventricular Assist Devices Among Medicare Beneficiaries JAMA, November 26, 2008; 300(20): 2398 - 2406. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. John, K. Liao, K. Lietz, F. Kamdar, M. Colvin-Adams, A. Boyle, L. Miller, and L. Joyce Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 351 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Leshnower, T. G. Gleason, M. L. O'Hara, A. Pochettino, Y. J. Woo, R. J. Morris, T. J. Gardner, and M. A. Acker Safety and Efficacy of Left Ventricular Assist Device Support in Postmyocardial Infarction Cardiogenic Shock Ann. Thorac. Surg., April 1, 2006; 81(4): 1365 - 1371. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Etz, H. Welp, H. H. Scheld, and C. Schmid Near fatal infection of a patient with a left ventricular assist device due to unrecognized fetal death Eur J Cardiothorac Surg, April 1, 2005; 27(4): 722 - 723. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |